Phase 2 Cachexia Clinical Trial to Evaluate the Efficacy and Safety of ASCA101 | MicrobiomeTrials← Back to trialsNCT07168226
Phase 2 Cachexia Clinical Trial to Evaluate the Efficacy and Safety of ASCA101
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-05-08Est. Completion: 2028-04-30
Enrollment target: 135 participants Locations- Samsung Medical Center, Seoul, Gangnam-gu, South Korea
- National Cancer Center, Gyeonggi-do, Goyang-si, South Korea
- Chung-Ang University Gwangmyeong Hospital, Gyeonggi-do, Gwangmyeong-si, South Korea
- Seoul ST. Mary's hospital, Seoul, Seocho-gu, South Korea
- Korea University Anam Hospital, Seoul, Seongbuk-gu, South Korea
- Ajou University Hospital, Gyeonggi-do, Suwon-si, South Korea
Other microbiome trials you might be interested in
Breast CancerCancer Cachexia
This study aims to evaluate the possible association between cancer cachexia and Gut Microbiota (GM) in patients with Br…
Multiple LocationsEst. completion May 31, 2028
Advanced CancerAnorexiaWeight LossInsomnia
Primary objective: This is a preliminary study to determine if Mirtazapine in comparison to placebo will improve appetit…
Houston, United StatesEst. completion Dec 31, 2027